The campaign to commemorate the work of the Muscular Dystrophy Association was created in partnership with agency Yes&.

Scientists present current evidence for a new gene therapy for Duchenne muscular dystrophy called delandistrogene moxeparvovec. AAN Evidence in Focus articles highlight the strength of the current ...

The article highlights that neurologists and other clinicians treating people with Duchenne muscular dystrophy should be aware of the limitations of this treatment and the need to monitor and ...

Oskoui, M., et al. (2025) Delandistrogene Moxeparvovec Gene Therapy in Individuals With Duchenne Muscular Dystrophy: Evidence in Focus Report of the AAN Guidelines Subcommittee. Neurology . doi ...

LONDON, ON, May 19, 2025 /CNW/ - On May 25, Canadians are walking, running, and rolling in support of the 30th annual Walk to Defeat Duchenne, the country's only national event dedicated to raising ...

Duchenne is a genetic disorder that slowly robs people of their muscle strength. Parent Project Muscular Dystrophy (PPMD) fights every single battle necessary to end Duchenne. We demand ...

"For nearly a decade, Sarepta has been a leader in advancing the treatment of Duchenne muscular dystrophy through innovative ... this treatment to additional people with Duchenne around the ...

To help neurologists, clinicians and families understand the current evidence for a new gene therapy for Duchenne muscular dystrophy called ... more severe over time. People with this disease ...

Progress in health and social care in European countries is helping many boys with Duchenne muscular dystrophy (DMD ... views on how to improve lives of people with the condition across Europe.